About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Biomarkers and Biology: Treatment Resistance in Advanced Prostate Cancer
By
Masonic Cancer Center, University of Minnesota
FEATURING
Joshua Lang
By
Masonic Cancer Center, University of Minnesota
FEATURING
Joshua Lang
0 views
February 20, 2024
Comments
0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY
ON
Related
Newest
48:38
UNC Lineberger Comprehensive Cancer Center
Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…
Feat.
N. Robertson
14:16
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…
Feat.
E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
Feat.
T. Powles,
B. Rini
27:04
Fengting Yan
Cancer Screening Molecular Tools
11:56
Ana Aparicio
Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
25:23
Houston Methodist Hospital
Whole-Body MRI: Past, Present, and Future
Feat.
N. Gupta
09:14
Robert Dreicer
AUA Advanced Prostate Cancer Guidelines: 2023 Update
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
05:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …
Feat.
S. Tagawa
34:26
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
Feat.
N. Reizine,
K. Tawagi
03:05
Benjamin L. Maughan
Testosterone Suppression and Recovery in Patients With Advanced Pros…
08:05
Total Health
Prostate Cancer Updates From ASCO® 2023
Feat.
T. Zhang
17:33
Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents…
Feat.
D. Jarrard
11:39
Oncology Data Advisor
Recent Prostate Cancer Updates
Feat.
U. Vaishampayan
21:17
Manish Kohli
Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…
22:27
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
Feat.
G. Sonpavde
09:45
Northwestern Medicine Oncology and Hematology
Differences Between Urologists and Medical Oncologists in the Manage…
Feat.
W. Catalona
19:07
Stanford Medicine
Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…
Feat.
G. Sonn
25:33
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…
Feat.
J. Berchuck,
A. Choudhury
